Disease-related hiPSC-derived Cell/Mutant hiPSC Culture and Isolation Service
Human induced pluripotent stem cells (hiPSCs) have emerged as a powerful tool for studying various diseases, particularly genetic disorders. By reprogramming somatic cells into pluripotent stem cells, researchers can create patient-specific hiPSCs that carry the genetic mutations associated with specific diseases. These hiPSCs can then be differentiated into various cell types to study disease mechanisms, screen drugs, and develop potential therapies.
Expert scientists at Creative Biolabs are passionate about offering disease-related hiPSC-derived cells/mutant hiPSCs you need to release you from the stressful and excessive workload process of cell reprogramming - giving you more time to focus on research.
Fig. 1 Use of disease-relevant hiPSCs to treat neurological diseases.1
Our hiPSC Disease Models
- Patient-derived hiPSC Disease Models
Patient-derived hiPSC disease models are reprogrammed from innate somatic cells without any genetic manipulation. These models retain the genetic background of the individual and are reprogrammed to a pluripotent state, thereby providing insights into how diseases manifest in specific patient populations.
- Genetically Engineered hiPSC Disease Models
Genetically engineered hiPSC disease models involve genetic modifications to introduce specific mutations related to a disease. These models can be generated using techniques such as CRISPR/Cas9 or other gene-editing tools.
- Induced hiPSC Disease Models
By introducing exogenous stimuli (e.g., Aβ1-42 peptide), researchers can create disease-like states in hiPSC-derived cells, allowing for a better understanding of disease mechanisms, drug responses, and potential therapeutic interventions.
Our hiPSC Control Models
- Healthy Control-derived hiPSC Models
Healthy control-derived hiPSC models are created from somatic cells (like skin or blood cells) of healthy individuals. These cells are reprogrammed into a pluripotent state, allowing them to differentiate into any cell type.
- Isogenic Control hiPSC Models
Isogenic control hiPSC models are derived from individuals with known genetic backgrounds. These lines are generated by either introducing specific disease-related mutations into healthy iPSCs or by correcting such mutations in patient-derived iPSCs, ensuring that no additional genetic alterations are made.
Disease Model Platforms
We are proud to provide disease-related hiPSC-derived cells or mutant hiPSCs with you for research use only, which significantly contribute to understanding various pathologies and the development of targeted therapies.
Neurological Diseases | Relevant Mutations | Available Cell Types |
---|---|---|
Alzheimer's disease | APOE 4/4, APOE 3/3, APOE 2/2, APOE 3/4, APOE 2/3, TREM2 KO, TREM2 R47H, APP A673V, APP A673T and PSEN M146L | NSCs, Cortical Neurons, GABAergic Neurons, Glutamatergic Neurons, Astrocytes and Microglia |
Parkinson's disease | Ataxin-3, PINK1, PARKIN, PARK2, SNCA A53T and LRRK2 | NSCs, Dopaminergic Neurons, Glutamatergic Neurons, Striatal Neurons, Astrocytes and Microglia |
Huntington's Disease | HTT 50 CAG | NSCs, Cortical Neurons, Glutamatergic Neurons, Striatal Neurons, |
Amyotrophic Lateral Sclerosis | SOD1, TDP43 and C9ORF72 | NSCs, Motor Neurons, Sensory Neurons |
Applications
- Disease Modeling
- Drug Discovery
- Toxicology Studies
Related Services
|
|
Reference
- McTague, Amy et al. "Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies." Front Genome Ed. 2021;3:630600. Distributed under Open Access license CC BY 4.0. The original image was modified.
- NeuroMab™ Anti-Amyloid Beta 1-15 Antibody(NRP-0422-P867) (Cat#: NRP-0422-P867)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-CD20 Antibody(NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Green Fluorescent Tau SH-SY5Y cell Line (Cat#: NCL2110P219)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)